Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src-Reference-Cited by-同舟云学术

Dasatinib, a Src inhibitor, sensitizes liver metastatic colorectal carcinoma to oxaliplatin in tumors with high levels of phospho-Src

Published:2016-04-20 Issue:22 Volume:7 Page:33111-33124
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Perez Marco¹,Lucena-Cacace Antonio¹,Marín-Gómez Luis Miguel¹²,Padillo-Ruiz Javier¹²,Robles-Frias Maria Jose³⁴,Saez Carmen¹³,Garcia-Carbonero Rocio⁵⁶,Carnero Amancio¹

Affiliation:

1. Instituto de Biomedicina de Sevilla, IBIS/Hospital Universitario Virgen del Rocío/ Universidad de Sevilla/Consejo Superior de Investigaciones Científicas, Seville, Spain

2. Department of General Surgery, Virgen del Rocío University Hospital, Seville, Spain

3. Department of Pathology, Virgen del Rocío University Hospital, Seville, Spain

4. Present address: HUVR-IBiS Biobank, Virgen del Rocío University Hospital, Seville, Spain

5. Department of Medical Oncology, Virgen del Rocío University Hospital, Seville, Spain

6. Present address: Department of Medical Oncology, 12 of October University Hospital, Madrid, Spain

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient‐derived xenograft model in colorectal cancer basic and translational research;Animal Models and Experimental Medicine;2022-12-21

2. Src inhibitor dasatinib sensitized gastric cancer cells to cisplatin;Medical Oncology;2022-12-16

3. Oridonin Enhances the Anti-Metastasis Effect of Oxaliplatinliplatin on Colorectal Cancer Liver Metastasis;Bulletin of Experimental Biology and Medicine;2021-11

4. Traditional Chinese medicine reverses cancer multidrug resistance and its mechanism;Clinical and Translational Oncology;2021-10-13

5. Epigenetic induction of lipocalin 2 expression drives acquired resistance to 5-fluorouracil in colorectal cancer through integrin β3/SRC pathway;Oncogene;2021-09-29